Nicotine and Application site erythema - a phase IV clinical study of FDA data

Summary:

Application site erythema is found among people who take Nicotine, especially for people who are female, 60+ old, have been taking the drug for < 1 month.

The phase IV clinical study analyzes which people take Nicotine and have Application site erythema. It is created by eHealthMe based on reports of 17,828 people who have side effects when taking Nicotine from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Nov, 30, 2022

17,828 people reported to have side effects when taking Nicotine.
Among them, 532 people (2.98%) have Application site erythema.

What is Nicotine?

Nicotine has active ingredients of nicotine. It is often used in quit smoking. eHealthMe is studying from 18,159 Nicotine users for its effectiveness, alternative drugs and more.

What is Application site erythema?

Application site erythema (redness of the skin at application site) is found to be associated with 1,257 drugs and 899 conditions by eHealthMe.

Number of Nicotine and Application site erythema reports submitted per year:

Could Nicotine cause Application site erythema?

* Approximation only. Some reports may have incomplete information.

Do you take Nicotine and have Application site erythema?

Check whether Application site erythema is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

How severe was Application site erythema and when was it recovered:

Application site erythema in Nicotine

Expand to all the drugs that have ingredients of nicotine:

Application site erythema and drugs with ingredients of nicotine (3,563 reports)

Alternative drugs to, pros and cons of Nicotine:

Nicotine (18,159 reports)

Common Nicotine side effects:

Drug ineffective: 1,834 reports
Dizziness: 847 reports
Stress and anxiety: 837 reports
Breathing difficulty: 782 reports

Browse all side effects of Nicotine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Application site erythema treatments and more:

Application site erythema (25,183 reports)

COVID vaccines that are related to Application site erythema:

Common drugs associated with Application site erythema:

All the drugs that are associated with Application site erythema:

Application site erythema (1,257 drugs)

Common conditions associated with Application site erythema:

Actinic keratosis: 1,775 reports
Pain: 1,618 reports
Quit smoking: 1,520 reports
Attention deficit hyperactivity disorder: 1,435 reports
High blood pressure: 833 reports
Migraine: 759 reports
Hair loss: 490 reports
Hormone replacement therapy: 476 reports

All the conditions that are associated with Application site erythema:

Application site erythema (899 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on nicotine (the active ingredients of Nicotine) and Nicotine (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.